Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03933813 · ClinicalTrials.gov registry record · Phase 1
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03933813 is a Phase 1 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 9 participants.
The verdict
NCT03933813, a Phase 1 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study tests the hypothesis that IV iron sucrose infusions given to iron deficient ovarian cancer patients prior to debulking surgery can improve pre-operative iron stores and decrease transfusion of packed red blood cells in the peri-operative period. 21 participants at least 18 years of age with epithelial ovarian cancer of any stage requiring neoadjuvant chemotherapy and surgery will be enrolled. Participants will be on study for a period of up to 3 months.
Interventions
- OTHER Iron Sucrose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-07-29 |
| Est. Completion | 2021-11-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03933813
The ClinicalTrials.gov registry entry for NCT03933813 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Iron Sucrose is the first listed.
NCT03933813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03933813 about?
NCT03933813 is a clinical study titled "Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients". This study tests the hypothesis that IV iron sucrose infusions given to iron deficient ovarian cancer patients prior to debulking surgery can improve pre-operative iron stores and decrease transfusion of packed red blood cells in the peri-operative period. 21 participants at least 18 years of age wi...
What is the current status of trial NCT03933813?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-07-29. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT03933813?
The interventions under investigation include: Iron Sucrose (OTHER).
Who is sponsoring clinical trial NCT03933813?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.